IMMUCELL CORP /DE/ — Director's Dealing 2026

Jan 29, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2026-01-27

Reporting Person: Fiori Timothy C (Director, Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-27	Stock Options (right to buy)	$6.265	A	120000	Acquired	2036-01-27	Common Stock (120000)	Direct

Footnotes

F1: Option grant made to Mr. Fiori in connection with his employment as Chief Financial Officer. The option shall be treated as an incentive stock option to the maximum extent permitted by the International Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 40,000 options on the first, second and third anniversary of the grant date.